Search in:
 Please use only plain characters
 (e.g., e, o, c and not è, ö or ç)
 		 
   
  Author   or    Free text  
   
  Author list  


© 2009 Elsevier Ltd. All rights reserved.
 
    Joint ECCO 15 - 34TH ESMO
    Multidisciplinary Congress
BERLIN, 20 - 24 SEPTEMBER 2009

Search Results     
SEARCHED IN ABSTRACT BY FREE TEXT: "NGR-hTNF"
Found: Abstract: 5 1 -  5   

Abstract O-9011:
NGR-hTNF, a vascular targeting agent (VTA), in previously treated patients with malignant pleural mesothelioma (MPM): a phase II study
V. Gregorc; G.L. Ceresoli; P.A. Zucali; F.G. De Braud; E. Bajetta; A. Santoro; M.G. Vigano; F. Caligaris Cappio; A. Lambiase; C. Bordignon 		 

Abstract P-1228:
Phase I study of NGR-hTNF, a vascular targeting agent (VTA), in combination withcisplatin in refractory patients (pts) with solid tumours
G. Citterio; F.G. De Braud; V. Gregorc; T.M. De Pas; C. Noberasco; S. Boselli; M. Giovannini; F. Caligaris Cappio; A. Lambiase; C. Bordignon 		 

Abstract P-6062:
NGR-hTNF, a vascular targeting agent (VTA), administered as single agent in patients (pts) with colorectal cancer (CRC) failing standard regimens: a phase II study
L. Rimassa; A. Santoro; A.F. Sobrero; F. Sclafani; V. Gregorc; V. Andretta; M.C. Tronconi; F. Caligaris Cappio; A. Lambiase; C. Bordignon 		 

Abstract P-6066:
Phase II study of two doses of NGR-hTNF, a vascular targeting agent (VTA), combined with capecitabine/oxaliplatin (XELOX) in colorectal cancer (CRC) patients failing standard regimens
A.F. Sobrero; A. Pessino; V. Andretta; E. Bennicelli; G. Fornarini; F. Caprioni; D. Comandini; L. Orsino; A. Lambiase; C. Bordignon 		 

Abstract P-6617:
Phase II study of NGR-hTNF, a selective vascular targeting agent (VTA), in previously treated patients (pts) with advanced hepatocellular carcinoma (HCC)
A. Santoro; G. Citterio; T. Pressiani; V. Gregorc; L. Rimassa; F.G. De Braud; G. Rossoni; F. Caligaris Cappio; A. Lambiase; C. Bordignon